|
Real-time Estimate
Cboe Europe
06:16:48 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 121.20 SEK | -0.16% |
|
-6.26% | +14.12% |
| 10-28 | Biogaia's Vice Chairman David Dangoor Sells Shares for SEK 19m | FW |
| 10-23 | SB1 Markets downgrades Biogaia to neutral, raises target price | FW |
Company Valuation: BioGaia AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 10,462 | 8,439 | 10,219 | 11,320 | 10,743 | 12,281 | - | - |
| Change | - | -19.33% | 21.1% | 10.77% | -5.09% | 14.31% | - | - |
| Enterprise Value (EV) 1 | 8,977 | 6,951 | 8,665 | 10,096 | 9,942 | 11,602 | 11,597 | 11,563 |
| Change | - | -22.57% | 24.67% | 16.51% | -1.52% | 16.7% | -0.04% | -0.29% |
| P/E | 53.3x | 22.6x | 28x | 32.2x | 32.3x | 30.4x | 25x | 22.2x |
| PBR | 5.57x | 4.28x | 5.03x | 6.57x | 8.18x | 9.37x | 8.93x | 8.34x |
| PEG | - | 0.3x | -12.95x | -8.33x | -5.92x | 1.4x | 1.2x | 1.7x |
| Capitalization / Revenue | 13.3x | 7.64x | 7.88x | 7.96x | 6.98x | 7.27x | 6.42x | 5.8x |
| EV / Revenue | 11.4x | 6.3x | 6.68x | 7.1x | 6.46x | 6.87x | 6.07x | 5.46x |
| EV / EBITDA | 31.9x | 18x | 18.5x | 20.2x | 22.7x | 21.6x | 18x | 15.8x |
| EV / EBIT | 35.4x | 19.2x | 19.6x | 23.8x | 24.1x | 22.3x | 18.6x | 16.4x |
| EV / FCF | 41.7x | - | - | - | 32.8x | 39.1x | 26.7x | 23.2x |
| FCF Yield | 2.4% | - | - | - | 3.05% | 2.56% | 3.75% | 4.31% |
| Dividend per Share 2 | 0.726 | 1.45 | 1.9 | 6.9 | 4 | 4.1 | 4.38 | 4.83 |
| Rate of return | 0.7% | 1.74% | 1.88% | 6.17% | 3.77% | 3.38% | 3.61% | 3.98% |
| EPS 2 | 1.944 | 3.7 | 3.62 | 3.48 | 3.29 | 4 | 4.86 | 5.48 |
| Distribution rate | 37.3% | 39.2% | 52.5% | 198% | 122% | 103% | 90.1% | 88.1% |
| Net sales 1 | 785.1 | 1,104 | 1,297 | 1,423 | 1,538 | 1,690 | 1,912 | 2,117 |
| EBITDA 1 | 281 | 385.3 | 468.4 | 500.1 | 437.1 | 536.5 | 646 | 731 |
| EBIT 1 | 253.7 | 361.5 | 443.1 | 423.4 | 412.5 | 520 | 623 | 707 |
| Net income 1 | 196.3 | 373.6 | 365.4 | 351.4 | 332.8 | 410.5 | 491.5 | 554 |
| Net Debt 1 | -1,485 | -1,488 | -1,554 | -1,224 | -801.3 | -679 | -684 | -718 |
| Reference price 2 | 103.60 | 83.57 | 101.20 | 111.90 | 106.20 | 121.40 | 121.40 | 121.40 |
| Nbr of stocks (in thousands) | 100,982 | 100,982 | 100,982 | 101,162 | 101,162 | 101,162 | - | - |
| Announcement Date | 2/4/22 | 2/3/23 | 2/7/24 | 2/12/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.35x | 6.87x | 21.63x | 3.38% | 1.24B | |
| 37.84x | 13.27x | 28.43x | 0.53% | 1,148B | |
| 39.67x | 6.67x | 18.75x | 1.97% | 652B | |
| 37.4x | 8.39x | 17.35x | 2.4% | 505B | |
| 21.45x | 5.21x | 12.93x | 2.51% | 384B | |
| 102.73x | 5.76x | 24.72x | 2.42% | 348B | |
| 21.89x | 5.76x | 13.88x | 2.85% | 294B | |
| 22.21x | 4.49x | 12.82x | 1.97% | 264B | |
| 28.66x | 7.33x | 13.12x | 2.23% | 244B | |
| -45.79x | 7.11x | 27.55x | 2.07% | 197B | |
| Average | 29.64x | 7.08x | 19.12x | 2.23% | 403.84B | |
| Weighted average by Cap. | 35.28x | 8.40x | 20.64x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIOG B Stock
- Valuation BioGaia AB
Select your edition
All financial news and data tailored to specific country editions
